Crowdonomics
This isn’t 20/20 GeneSystems’s most recent raise. Reg CF · Convertible Note · Oct 2025 (Closed) is more current.View latest round
20/20 GeneSystems

Reg A+ · Preferred Stock · Feb 2020

ClosedReg A+Preferred Equity
via StartEngine · last checked Sep 25, 2026View campaign
Raised
$1.4M
Investors
1,388
$1K avg
Estimated pre-money
$35.8M
—

Raised over time

Cumulative raisedInvestors
$1.4M$705K$0
420
Feb 20, 2020 · openedMay 16, 2020 · last reading
$1.0M raised — Apr 22, 2020

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Sep 25, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$35.8M
Price / share$4.40

Estimated, not stated: $4.40 × 8,137,355 securities outstanding as of Dec 31, 2019 (Form 1-A/A filed Dec 31, 2019).

Offering details

Target—
Max—
Min investment$502
OpenedFeb 20, 2020
Deadline—
ClosedMay 16, 2020
Days active86

Links & provenance

Source: Manual
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.